Spring Health vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI mental health benefits platform. $3.3B valuation. 50M+ lives. Raised $460M+. Acquiring Alma (Jan 2026). Founded 2016, NYC. Potential IPO candidate 2026. Private.
About
Spring Health is a global mental health technology company founded in 2016 by CEO April Koh and President Adam Chekroud, headquartered in New York City. Raised over $460M including a $100M Series E (July 2024) led by Generation Investment Management at $3.3B valuation. April Koh became the youngest woman to lead a multibillion-dollar startup at 29.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.